Chemical formula: C₁₈H₁₄F₄N₂O₄S Molecular mass: 430.373 g/mol PubChem compound: 2375
Bicalutamide is indicated for:
Population group: men, only adults (18 years old or older)
Bicalutamide is indicated either alone or as adjuvant to radical prostatectomy or radiotherapy in patients with locally advanced prostate cancer at high risk for disease progression.
Bicalutamide is also indicated for the management of patients with locally advanced, non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Bicalutamide is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
